<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>A. capillaris</italic> (Yin-Chen) is a famous traditional Chinese medicine (TCM) for treating acute and chronic hepatitis in China [
 <xref rid="B62" ref-type="bibr">62</xref>]. Geng et al. [
 <xref rid="B63" ref-type="bibr">63</xref>] isolated 14 compounds, 8
 <italic>S</italic>-deca-9-en-4,6-diyne-1,8-diol (
 <bold>105</bold>), (
 <italic>S</italic>)-deca-4,6,8-triyne-1,3-diol (
 <bold>106</bold>), (
 <italic>S</italic>)-3-hydroxyundeca-5,7,9-triynoic acid (
 <bold>107</bold>), 3
 <italic>S</italic>-Hydroxyundeca-5,9-triynoic acid 3-
 <italic>O</italic>-
 <italic>β</italic>-D-glucopyranoside (
 <bold>108</bold>), Atractylodin (
 <bold>109</bold>), Dendroarboreol B (
 <bold>110</bold>), Dehydrofalcarinol (
 <bold>111</bold>), Dehydrofalcarindiol (
 <bold>112</bold>), (
 <italic>E</italic>)-deca-2-en-4,10-diol (
 <bold>113</bold>), (
 <italic>Z</italic>)-deca-2-en-4,10-diol (
 <bold>114</bold>), 8-diol 1-
 <italic>O</italic>-
 <italic>β</italic>-D-glucopyranoside (
 <bold>115</bold>), 3
 <italic>S</italic>,8
 <italic>S</italic>-dihydroxydec-9-ene-4,6-diyne 1-
 <italic>O</italic>-
 <italic>β</italic>-D-glucopyranoside (
 <bold>116</bold>), 5-benzylthiophencarboxylic acid (
 <bold>117</bold>), and 2-methyl-6-phenyl-4H-pyran-4-one (
 <bold>118</bold>), from 
 <italic>A. capillaris</italic>. All the compounds were assayed for their anti-HBV activity, and the structure-activity relationships were summarized based on the biological effects. In particular, compound 
 <bold>108</bold> could significantly inhibit the secretions of HBsAg, HBeAg, and HBV-DNA replication with IC
 <sub>50</sub> values of 197.2 (SI &gt; 5.1), 48.7 (SI &gt; 20.5), and 9.8 (SI &gt; 102) 
 <italic>μ</italic>M. Hydroxyl and glycosyl groups are preferable for maintaining activity. In subsequent studies, Geng et al. [
 <xref rid="B64" ref-type="bibr">64</xref>] found that 3
 <italic>S</italic>,8
 <italic>S</italic>-dihydroxydec-9-en-4,6-yne 1-
 <italic>O</italic>-(6′-O-caffeoyl)-
 <italic>β</italic>-D-glucopyranoside and 3
 <italic>S</italic>,8
 <italic>S</italic>-dihydroxydec-9-en-4,6-yne 1-
 <italic>O</italic>-(2′-
 <italic>O</italic>-caffeoyl)-
 <italic>β</italic>-D-glucopyranoside (
 <bold>119-120</bold>) had the activity against the secretions of HBsAg and HBeAg and HBV DNA replication. Especially, compounds 
 <bold>119</bold> and 
 <bold>120</bold> inhibited HBV-DNA replication with IC
 <sub>50</sub> values of 0.077 ± 0.04 and 0.0127 ± 0.05 mM, with SI values of 23.6 and 17.1, respectively. Compounds 
 <bold>119</bold> and 
 <bold>120</bold> as a pair of isomers showed similar inhibition on HBsAg secretion with IC
 <sub>50</sub> values of 0.797 ± 0.23 mM (SI = 2.1) and 0.887 ± 0.20 mM (SI =2.3), but no activity against HBeAg secretion. Compound 
 <bold>119</bold> displayed the highest inhibitory activity on HBV-DNA replication with an IC
 <sub>50</sub> value of 0.077 ± 0.04 mM (SI = 23.6), and compound 
 <bold>120</bold> showed slightly decreased activity with an IC
 <sub>50</sub> value of 0.127 ± 0.05 mM (SI = 17.1). The above analyses suggested that the caffeoyl group played important role in maintaining the anti-HBV activity but the substitution position may not be crucial. The chemical structures of compounds 
 <bold>105</bold>~120 are shown in 
 <xref ref-type="fig" rid="fig8">Figure 8</xref>.
</p>
